An information theoretic method to identify combinations of genomic alterations that promote glioblastoma.
暂无分享,去创建一个
Raul Rabadan | Antonio Iavarone | Jiguang Wang | R. Melamed | A. Iavarone | R. Rabadán | Jiguang Wang | Rachel D Melamed
[1] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[2] L. Stein,et al. A human functional protein interaction network and its application to cancer data analysis , 2010, Genome Biology.
[3] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[4] Niko Beerenwinkel,et al. Modeling Mutual Exclusivity of Cancer Mutations , 2014, RECOMB.
[5] C. Sander,et al. Mutual exclusivity analysis identifies oncogenic network modules. , 2012, Genome research.
[6] Giancarlo Mauri,et al. Inferring Tree Causal Models of Cancer Progression with Probability Raising , 2013, bioRxiv.
[7] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[8] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.
[9] Roded Sharan,et al. Simultaneous Identification of Multiple Driver Pathways in Cancer , 2013, PLoS Comput. Biol..
[10] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[11] Pooja Mittal,et al. A novel signaling pathway impact analysis , 2009, Bioinform..
[12] Eli Upfal,et al. Algorithms for Detecting Significantly Mutated Pathways in Cancer , 2010, RECOMB.
[13] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[14] Andrew P Feinberg,et al. A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcript , 2011, Proceedings of the National Academy of Sciences of the United States of America.
[15] B. Clurman,et al. Cyclin E in normal and neoplastic cell cycles , 2005, Oncogene.
[16] Giovanni Parmigiani,et al. Patient-oriented gene set analysis for cancer mutation data , 2010, Genome Biology.
[17] C. Sander,et al. Pattern discovery and cancer gene identification in integrated cancer genomic data , 2013, Proceedings of the National Academy of Sciences.
[18] F. Markowetz,et al. Cancer Evolution: Mathematical Models and Computational Inference , 2014, Systematic biology.
[19] David Haussler,et al. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..
[20] C. Croce,et al. Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[21] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[22] C. Sander,et al. Automated Network Analysis Identifies Core Pathways in Glioblastoma , 2010, PloS one.
[23] Xiang-Sun Zhang,et al. Detecting and analyzing differentially activated pathways in brain regions of Alzheimer's disease patients. , 2011, Molecular bioSystems.
[24] Y. Colin,et al. αII-Spectrin Is Critical for Cell Adhesion and Cell Cycle* , 2009, Journal of Biological Chemistry.
[25] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[26] Luca Laurenti,et al. Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia , 2014, eLife.
[27] D. Housman,et al. Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis , 2009, Proceedings of the National Academy of Sciences.
[28] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.
[29] Benjamin J. Raphael,et al. De novo discovery of mutated driver pathways in cancer , 2011 .
[30] Gregory A Petsko,et al. No stone unturned , 2010, Genome Biology.
[31] F. James Rohlf,et al. Biometry: The Principles and Practice of Statistics in Biological Research , 1969 .
[32] Long Yu,et al. BRSK2 is regulated by ER stress in protein level and involved in ER stress-induced apoptosis. , 2012, Biochemical and biophysical research communications.
[33] Christopher A. Miller,et al. Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors , 2011, BMC Medical Genomics.
[34] Zaher Dawy,et al. An approximation to the distribution of finite sample size mutual information estimates , 2005, IEEE International Conference on Communications, 2005. ICC 2005. 2005.
[35] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[36] Long Yu,et al. APC/CCdh1 Targets Brain-Specific Kinase 2 (BRSK2) for Degradation via the Ubiquitin-Proteasome Pathway , 2012, PloS one.
[37] Dimitris Anastassiou,et al. Inference of Disease-Related Molecular Logic from Systems-Based Microarray Analysis , 2006, PLoS Comput. Biol..